title: PCSK9 inhibitors and diabetes risk: a question worth asking?
authors: Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK naveed.sattar@glasgow.ac.uk.
authors: Naveed
authors: N
authors: Sattar
mesh_terms: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D003920:Diabetes Mellitus; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000071449:Proprotein Convertase 9
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9